{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:17:56Z","timestamp":1791919076318,"version":"4.3.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.pharep.2017.02.006","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T16:30:16Z","timestamp":1488213016000},"page":"625-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Nrf2 and NF-\u03baB modulation by Plumbagin attenuates functional, behavioural and biochemical deficits in rat model of neuropathic pain"],"prefix":"10.1007","volume":"69","author":[{"given":"Vijay","family":"Arruri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanth","family":"Komirishetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Areti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva Kumar Naik","family":"Dungavath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"5","key":"10.1016\/j.pharep.2017.02.006_bib0005","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.pharep.2016.06.010","article-title":"Intravenous lidocaine infusions in a multidirectional model of treatment of neuropathic pain patients","volume":"68","author":"Przeklasa-Muszyaska","year":"2016","journal-title":"Pharmacol Rep"},{"issue":"9","key":"10.1016\/j.pharep.2017.02.006_bib0010","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S1474-4422(14)70102-4","article-title":"Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms","volume":"13","author":"Jensen","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharep.2017.02.006_bib0015","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1097\/j.pain.0000000000000387","article-title":"Functional brain imaging: what has it brought to our understanding of neuropathic pain? A special focus on allodynic pain mechanisms","volume":"157","author":"Peyron","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.pharep.2017.02.006_bib0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pbb.2015.11.008","article-title":"Spontaneous and evoked pain-associated behaviors in a rat model of neuropathic pain respond differently to drugs with different mechanisms of action","volume":"141","author":"Murai","year":"2016","journal-title":"Pharmacol Biochem Behavior"},{"key":"10.1016\/j.pharep.2017.02.006_bib0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2014.01.006","article-title":"Oxidative stress and nerve damage: role in chemotherapy induced peripheral neuropathy","volume":"2","author":"Areti","year":"2014","journal-title":"Redox Biol"},{"issue":"8","key":"10.1016\/j.pharep.2017.02.006_bib0030","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"Baron","year":"2010","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.pharep.2017.02.006_bib0035","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.mayocp.2015.01.018","article-title":"Neuropathic pain: principles of diagnosis and treatment","volume":"90","author":"Gilron","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2011.01.022","article-title":"Evaluation of milnacipran, in comparison with amitriptyline, on cold and mechanical allodynia in a rat model of neuropathic pain","volume":"655","author":"Berrocoso","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.pharep.2017.02.006_bib0045","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype to reveal neural mechanisms","volume":"73","author":"Von Hehn","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.pharep.2017.02.006_bib0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/syn.21902","article-title":"Changes in the expression of IL-6-mediated MicroRNAs in the dorsal root ganglion under neuropathic pain in mice","volume":"70","author":"Hori","year":"2016","journal-title":"Synapse"},{"issue":"3","key":"10.1016\/j.pharep.2017.02.006_bib0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action","volume":"83","author":"Sindrup SrH","year":"1999","journal-title":"Pain"},{"issue":"11","key":"10.1016\/j.pharep.2017.02.006_bib0060","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/archneur.60.11.1524","article-title":"Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations","volume":"60","author":"Dworkin","year":"2003","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.pharep.2017.02.006_bib0065","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.bbrc.2010.03.014","article-title":"NF-\u03baB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy","volume":"394","author":"Kumar","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.pharep.2017.02.006_bib0070","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.2042-7158.2011.01264.x","article-title":"Antihyperalgesic activity of verbascoside in two models of neuropathic pain","volume":"63","author":"Isacchi","year":"2011","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0075","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3940(94)11154-B","article-title":"Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain","volume":"184","author":"Clatworthy","year":"1995","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0085","first-page":"1","article-title":"Peripheral nerve injury and TRPV1-expressing primary afferent C-fibers cause opening of the blood-brain barrier","volume":"6","author":"Beggs","year":"2010","journal-title":"Mol Pain"},{"issue":"5","key":"10.1016\/j.pharep.2017.02.006_bib0090","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1124\/mi.4.5.3","article-title":"The role of reactive oxygen species (ROS) in persistent pain","volume":"4","author":"Chung","year":"2004","journal-title":"Mol Interv"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0095","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jneuroim.2006.12.009","article-title":"Neutrophils invade lumbar dorsal root ganglia after chronic constriction injury of the sciatic nerve","volume":"184","author":"Morin","year":"2007","journal-title":"J Neuroimmunol"},{"issue":"5","key":"10.1016\/j.pharep.2017.02.006_bib0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbi.2006.10.013","article-title":"Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve","volume":"21","author":"Hu","year":"2007","journal-title":"Brain Behav Immun"},{"issue":"12","key":"10.1016\/j.pharep.2017.02.006_bib0105","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1016\/j.fct.2012.08.046","article-title":"Anti diabetic effect of Plumbagin isolated from Plumbago zeylanica L. root and its effect on GLUT4 translocation in streptozotocin-induced diabetic rats","volume":"50","author":"Sunil","year":"2012","journal-title":"Food Chem Toxicol"},{"issue":"5","key":"10.1016\/j.pharep.2017.02.006_bib0110","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1111\/j.1471-4159.2009.06552.x","article-title":"Plumbagin, a novel Nrf2\/ARE activator, protects against cerebral ischemia","volume":"112","author":"Son","year":"2010","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.pharep.2017.02.006_bib0115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jphs.2015.06.005","article-title":"Plumbagin inhibits growth of gliomas in vivo via suppression of FOXM1 expression","volume":"128","author":"Niu","year":"2015","journal-title":"J Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.pharep.2017.02.006_bib0120","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2013.03.041","article-title":"Naphthazarin protects against glutamate-induced neuronal death via activation of the Nrf2\/ARE pathway","volume":"433","author":"Son","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.pharep.2017.02.006_bib0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.neuint.2003.09.009","article-title":"Glial activation and pathological pain","volume":"45","author":"Wieseler-Frank","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharep.2017.02.006_bib0130","doi-asserted-by":"crossref","first-page":"593","DOI":"10.2174\/1570159X14666151126215358","article-title":"Potential therapeutic benefits of maintaining mitochondrial health in peripheral neuropathies","volume":"14","author":"Areti","year":"2015","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S1359-6446(05)03637-8","article-title":"The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets","volume":"11","author":"Myers","year":"2006","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.pharep.2017.02.006_bib0140","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10571-014-0137-7","article-title":"Possible involvement of convergent nociceptive input to medullary dorsal horn neurons in intraoral hyperalgesia following peripheral nerve injury","volume":"35","author":"Terayama","year":"2015","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharep.2017.02.006_bib0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.neuropharm.2016.09.027","article-title":"Combination strategy of PARP inhibitor with antioxidant prevent bioenergetic deficits and inflammatory changes in CCI-induced neuropathy","volume":"113","author":"Komirishetty","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2011.03.087","article-title":"Oxidative stress and Nrf2 in the pathophysiology of diabetic neuropathy: old perspective with a new angle","volume":"408","author":"Negi","year":"2011","journal-title":"Biochem Biophys Res commun"},{"issue":"10","key":"10.1016\/j.pharep.2017.02.006_bib0155","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.freeradbiomed.2008.09.001","article-title":"Nrf2-induced antioxidant protection: a promising target to counteract ROS-mediated damage in neurodegenerative disease?","volume":"45","author":"de Vries","year":"2008","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.pharep.2017.02.006_bib0160","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/jpet.110.170852","article-title":"Anti-inflammatory and analgesic effect of Plumbagin through inhibition of nuclear factor-kappa B activation","volume":"335","author":"Pei","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.pharep.2017.02.006_bib0165","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.pharep.2015.03.001","article-title":"Antidepressant-like activity of Plumbagin in unstressed and stressed mice","volume":"67","author":"Dhingra","year":"2015","journal-title":"Pharmacol Rep"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0170","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/00006534-198901000-00024","article-title":"Functional evaluation of complete sciatic, peroneal, and posterior tibial nerve lesions in the rat","volume":"83","author":"Bain","year":"1989","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.pharep.2017.02.006_bib0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.brainresbull.2004.01.006","article-title":"Attenuation of mechanical but not thermal hyperalgesia by electroacupuncture with the involvement of opioids in rat model of chronic inflammatory pain","volume":"63","author":"Huang","year":"2004","journal-title":"Brain Res Bull"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0180","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1213\/ANE.0b013e31826e0fe0","article-title":"A pan-caspase inhibitor reduces myocyte apoptosis and neuropathic pain in rats with chronic constriction injury of the sciatic nerve","volume":"116","author":"Gradl","year":"2013","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0190","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.pain.2004.01.029","article-title":"Ethosuximide reverses paclitaxel-and vincristine-induced painful peripheral neuropathy","volume":"109","author":"Flatters","year":"2004","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0195","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2010.08.050","article-title":"Differential effect of spironolactone in chronic constriction injury and vincristine-induced neuropathic pain in rats","volume":"648","author":"Jaggi","year":"2010","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0200","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/abio.2002.5676","article-title":"Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy","volume":"306","author":"Sastry","year":"2002","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pharep.2017.02.006_bib0205","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal Biochem"},{"issue":"8","key":"10.1016\/j.pharep.2017.02.006_bib0210","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1007\/s11064-016-1914-0","article-title":"Morin mitigates chronic constriction injury (CCI)-induced peripheral neuropathy by inhibiting oxidative stress induced PARP over-activation and neuroinflammation","volume":"41","author":"Komirishetty","year":"2016","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharep.2017.02.006_bib0215","first-page":"e3393","article-title":"Chronic constriction of the sciatic nerve and pain hypersensitivity testing in rats","volume":"61","author":"Austin","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1016\/j.pharep.2017.02.006_bib0220","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.lfs.2016.02.085","article-title":"PARP inhibition attenuates neuroinflammation and oxidative stress in chronic constriction injury induced peripheral neuropathy","volume":"150","author":"Komirishetty","year":"2016","journal-title":"Life Sci"},{"issue":"2","key":"10.1016\/j.pharep.2017.02.006_bib0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejphar.2004.03.051","article-title":"Pharmacological characterization of the chronic constriction injury model of neuropathic pain","volume":"491","author":"De Vry","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharep.2017.02.006_bib0230","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/089771504774129955","article-title":"Methodological evaluation to analyze functional recovery after sciatic nerve injury","volume":"21","author":"Schiaveto de Souza","year":"2004","journal-title":"J Neurotrauma"},{"issue":"2","key":"10.1016\/j.pharep.2017.02.006_bib0235","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3959(90)90022-6","article-title":"Further evidence for \u2018pain-related\u2019 behaviours in a model of unilateral peripheral mononeuropathy","volume":"41","author":"Attal","year":"1990","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0240","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0304-3959(96)03103-X","article-title":"Both motor and sensory abnormalities contribute to changes in foot posture in an experimental rat neuropathic model","volume":"67","author":"Na","year":"1996","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.pharep.2017.02.006_bib0245","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0891-5849(01)00597-4","article-title":"A role for free radicals and nitric oxide in delayed recovery in aged rats with chronic constriction nerve injury","volume":"31","author":"Khalil","year":"2001","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-2999(03)01753-9","article-title":"Pharmacological sensitivity and gene expression analysis of the tibial nerve injury model of neuropathic pain","volume":"470","author":"Hofmann","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharep.2017.02.006_bib0255","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s11064-015-1555-8","article-title":"Activated microglia contribute to convergent nociceptive inputs to spinal dorsal horn neurons and the development of neuropathic pain","volume":"40","author":"Yamamoto","year":"2015","journal-title":"Neurochem Res"},{"issue":"4","key":"10.1016\/j.pharep.2017.02.006_bib0260","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.neures.2009.04.010","article-title":"Analgesic effect of milnacipran is associated with c-Fos expression in the anterior cingulate cortex in the rat neuropathic pain model","volume":"64","author":"Takeda","year":"2009","journal-title":"Neurosci Res"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0265","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0304-3959(03)00254-9","article-title":"Cyclo-oxygenase-2 contributes to central sensitization in rats with peripheral inflammation","volume":"105","author":"Seybold","year":"2003","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.pharep.2017.02.006_bib0270","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0006-8993(95)00715-3","article-title":"Mechanisms of tumor necrosis factor-alpha (TNF-a) hyperalgesia","volume":"692","author":"Watkins","year":"1995","journal-title":"Brain Res"},{"issue":"6","key":"10.1016\/j.pharep.2017.02.006_bib0275","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10571-014-0070-9","article-title":"Anti-apoptotic and anti-oxidative roles of quercetin after traumatic brain injury","volume":"34","author":"Yang","year":"2014","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"10.1016\/j.pharep.2017.02.006_bib0280","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10571-015-0272-9","article-title":"Fisetin imparts neuroprotection in experimental diabetic neuropathy by modulating Nrf2 and NF-\u03baB pathways","volume":"36","author":"Sandireddy","year":"2015","journal-title":"Cell Mol Neurobiol"},{"issue":"36","key":"10.1016\/j.pharep.2017.02.006_bib0285","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.2174\/09298673113209990151","article-title":"Neuroprotection by resveratrol in diabetic neuropathy: concepts & mechanisms","volume":"20","author":"Kumar","year":"2013","journal-title":"Curr Med Chem"},{"issue":"5","key":"10.1016\/j.pharep.2017.02.006_bib0290","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1089\/ars.2004.6.811","article-title":"Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rat neurons against oxidative stress","volume":"6","author":"Scapagnini","year":"2004","journal-title":"Antioxid Redox Signal"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016302900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:57Z","timestamp":1752611817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2017.02.006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1734114016302900"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2017.02.006","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nrf2 and NF-\u03baB modulation by Plumbagin attenuates functional, behavioural and biochemical deficits in rat model of neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2017.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Sp. z o.o. on behalf of Institute of Pharmacology, Polish Academy of Sciences.","name":"copyright","label":"Copyright"}]}}